Anzeige
Mehr »
Freitag, 18.07.2025 - Börsentäglich über 12.000 News
Klinisch validiert. Vertriebsbereit. Und kurz vor der FDA-Zulassung.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40WGA | ISIN: GB00BQVXM815 | Ticker-Symbol: 5HU0
Frankfurt
17.07.25 | 21:49
1,420 Euro
-0,70 % -0,010
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
HEMOGENYX PHARMACEUTICALS PLC Chart 1 Jahr
5-Tage-Chart
HEMOGENYX PHARMACEUTICALS PLC 5-Tage-Chart
RealtimeGeldBriefZeit
1,4401,66017.07.

Aktuelle News zur HEMOGENYX PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiHemogenyx Pharmaceuticals PLC: Hemogenyx Awarded Grant153Hemogenyx Pharmaceuticals Awarded G-Rex® Grant to Support Scalable, Cost-Optimized CAR-T Manufacturing LONDON, UK / ACCESS Newswire / July 16, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased...
► Artikel lesen
MiHemogenyx Pharma Plc - Hemogenyx Awarded Grant-
30.06.Hemogenyx Pharma Plc - Total Voting Rights-
17.06.Hemogenyx Pharmaceuticals PLC Announces Clearance to Proceed with Pediatric Expansion148THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018...
► Artikel lesen
17.06.Hemogenyx Pharma Plc - Clearance to Proceed with Pediatric Expansion1
03.06.TRADING UPDATES: Valereum invests in Blubird; Hemogenyx raises funds6
03.06.Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing238THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018...
► Artikel lesen
03.06.Hemogenyx Pharma Plc - Placing to Raise £451,250 and Director's Dealing1
HEMOGENYX PHARMACEUTICALS Aktie jetzt für 0€ handeln
03.06.Hemogenyx Pharmaceuticals PLC - Second Patient Passes Initial Safety Tests157Second Patient Treated with HG-CT-1 CAR-T Therapy Successfully Passes Initial Safety Evaluation LONDON, UNITED KINGDOM / ACCESS Newswire / June 3, 2025 / Hemogenyx Pharmaceuticals plc is pleased to...
► Artikel lesen
03.06.Hemogenyx Pharma Plc - Second Patient Passes Initial Safety Tests1
30.05.Hemogenyx Pharma Plc - Total Voting Rights-
29.05.Hemogenyx Pharma Plc - Result of AGM-
14.05.Hemogenyx erweitert AML-Studie auf pädiatrische Patienten3
14.05.Hemogenyx expands AML trial to include pediatric patients2
14.05.Hemogenyx Pharmaceuticals PLC Announces Pediatric Amendment to Clinical Protocol188Amendment to Clinical Protocol for HG-CT-1 to Include Pediatric Patients with R/R AML LONDON, UNITED KINGDOM / ACCESS Newswire / May 14, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to...
► Artikel lesen
14.05.Hemogenyx Pharma Plc - Pediatric Amendment to Clinical Protocol1
13.05.Hemogenyx Pharma Plc - AGM Correction-
08.05.Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing172THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018...
► Artikel lesen
08.05.Hemogenyx Pharma Plc - Placing to Raise £451,250 and Director's Dealing2
02.05.TRADING UPDATES: GlobalData suspends buyback; Hemogenyx trial progress2
Weiter >>
64 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1